Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men. Baltimore Longitudinal Study of Aging
Overview
Affiliations
Many studies have shown cross-sectional (and two small studies, longitudinal) declines in total and/or free testosterone (T) levels, with age, in men. The extent to which decline in T is the result of the aging process per se, as opposed to chronic illness, medication use, and other age-related factors, remains controversial. The frequency with which aging leads to T levels consistent with hypogonadism has also not been defined. These issues bear on the potential use of T replacement in aging men, because aging and hypogonadism have, in common, reduced bone and lean body mass and muscle strength and increased total and abdominal fat. We measured T and sex hormone-binding globulin (SHBG), by RIA, in stored samples from 890 men in the Baltimore Longitudinal Study on Aging. Using a mixed-effects model, we found independent effects of age and date of sampling to reduce T levels. After compensating for date effects, which investigation suggested was artifactual, we observed significant, independent, age-invariant, longitudinal effects of age on both T and free T index (free T index = T/SHBG), with an average change of -0.124 nmol/L.yr and -0.0049 nmol T/nmol SHBG.yr. T, but not free T index, also decreased with increasing body mass index. Use of beta-blocking drugs was associated with higher T and higher free T index levels. Using total T criteria, incidence of hypogonadal T levels increased to about 20% of men over 60, 30% over 70 and 50% over 80 yr of age, and even greater percentages when free T index criteria were employed. Our observations of health factor independent, age-related longitudinal decreases in T and free T, resulting in a high frequency of hypogonadal values, suggest that further investigation of T replacement in aged men, perhaps targeted to those with the lowest serum T concentrations, are justified.
Corsini C, Pozzi E, Belladelli F, Bertini A, Negri F, Raffo M Int J Impot Res. 2025; .
PMID: 39987403 DOI: 10.1038/s41443-025-01029-2.
Hormones, Age, and Erectile Dysfunction: Should Routine Testing Be Part of the Initial Evaluation?.
Porav-Hodade D, Gherasim R, Kosovski I, Voidazan T, Crisan N, Bogdan P Diagnostics (Basel). 2025; 15(3).
PMID: 39941224 PMC: 11816566. DOI: 10.3390/diagnostics15030294.
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge.
Fossa S, Bjerner L, Tandstad T, Brydoy M, Dahl A, Nome R Eur Urol Open Sci. 2025; 72:10-16.
PMID: 39897186 PMC: 11786855. DOI: 10.1016/j.euros.2024.12.010.
A time for sex: circadian regulation of mammalian sexual and reproductive function.
Aten S, Ramirez-Plascencia O, Blake C, Holder G, Fishbein E, Vieth A Front Neurosci. 2025; 18():1516767.
PMID: 39834701 PMC: 11743455. DOI: 10.3389/fnins.2024.1516767.
Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes.
Ruggiero C, Caffarelli C, Calsolaro V, Tafaro L, Riuzzi F, Bubba V Drugs Aging. 2025; 42(1):21-38.
PMID: 39775765 DOI: 10.1007/s40266-024-01163-4.